NASDAQ:ACST
Acasti Pharma Stock Company Profile
$2.90
+0.0200 (+0.694%)
At Close: Apr 24, 2024
Information
3009 boulevard de la Concorde East, Suite 102
Laval QC H7E 2B5
450 687 2262
www.acastipharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
